Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2022 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (116)	4/25/2022 6:51:39 PM
From: technetium	Respond to of 267

I started following NKTR ages ago when they worked on an inhalable form of insulin. IIRC, it went nowhere, as it apparently led to an increase in anti-insulin antibodies, as well as an increase in lung cancer amongst smokers, and was hard to dose in a controllable fashion. After all, if someone has a stuffy nose due to hay fever (allergies) or the common cold, it will be difficult to get the same dose into your lungs every time. thestreet.com I stopped following them after that little mishap.